Philip Friedlander
3PUBLICATIONS
35CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Mar 17, 2025
PGV001, a Multi-Peptide Personalized Neoantigen Vaccine Platform: Phase I Study in Patients with Solid and Hematologic Malignancies in the Adjuvant Setting.Mansi Saxena, Thomas U Marron, Julia Kodysh
|Sep 20, 2018
A whole-blood RNA transcript-based gene signature is associated with the development of CTLA-4 blockade-related diarrhea in patients with advanced melanoma treated with the checkpoint inhibitor tremelimumab.Philip Friedlander, Kevin Wood, Karl Wassmann
|Aug 16, 2017
Whole-blood RNA transcript-based models can predict clinical response in two large independent clinical studies of patients with advanced melanoma treated with the checkpoint inhibitor, tremelimumab.Philip Friedlander, Karl Wassmann, Alan M Christenfeld
Pageof 1
Frequent Collaborators
1 joint publications
Mansi Saxena
1 joint publications
Thomas U Marron
1 joint publications
Julia Kodysh
1 joint publications
John P Finnigan
1 joint publications
Sayali Onkar
1 joint publications
Anna Kaminska
1 joint publications
Kevin Tuballes
1 joint publications
Ruiwei Guo
1 joint publications
Rachel Lubong Sabado
1 joint publications
Timothy J O'Donnell
